MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202521110185 A) filed by Prof. Shubham Bajirao Ahir; Prof. Mukesh Wamanrao Babhulkar; Prof. Mahesh Bhanudas Narkhede; Dr Pavan Prabhakar Chinchole; Prof. Rahul Ashok Darakhe; Prof. Kisan Navalsing Pawar; Prof Bhavesh Mandhwale; and Ms. Vaishnavi Santosh Anjulkar, Khamgaon, Maharashtra, on Nov. 12, 2025, for 'a system and method for quality control and stability testing of pharmaceutical formulations.'

Inventor(s) include Prof. Shubham Bajirao Ahir; Prof. Mukesh Wamanrao Babhulkar; Prof. Mahesh Bhanudas Narkhede; Dr Pavan Prabhakar Chinchole; Prof. Rahul Ashok Darakhe; Prof. Kisan Navalsing Pawar; Prof Bhavesh Mandhwale; and Ms. Vaishnavi Santosh Anjulkar.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "A System and Method for Quality Control and Stability Testing of Pharmaceutical Formulations This disclosure describes a system and method for performing quality control and stability testing of pharmaceutical formulations with an intelligent AI-enabled and sensor-fusion enabled platform. The system includes a formulation-twin generation module to generate a digital twin of each batch, a multi-sensor acquisition and fusion module to continuously capture environmental and formulation parameters in real-time, an AI-based evaluation module that will compute a Dynamic Quality Index (DQI) and Adaptive Stability Score (ASS), and a predictive degradation modeling module that forecasts potency and shelf-life degradation. A blockchain-enabled traceability module creates an immutable, secure log of analytical data and a visualization dashboard to show compliance and stability reports and other important information. The method will support non-destructive, continuous and predictive assessment of stability through adaptive learning and digital-twin updates, transforming the conventional static process of stability testing into a proactive, self-correcting and regulatory-compliant operation quality assurance process for pharmaceutical formulations."

Disclaimer: Curated by HT Syndication.